SCHEMBL24110463

SCHEMBL24110463

CN(C)CCn1c2c(c3cccnc31)OCCCC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 12/20 0.43
KDM4E B2RXH2 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HTR2A P28223 4/20 0.38
HTR2C P28335 4/20 0.38
DRD3 P35462 2/20 0.38
CHRM2 P08172 1/20 0.38
HTR1A P08908 1/20 0.38
CHRM5 P08912 1/20 0.38
ADRA2A P08913 1/20 0.38
DRD2 P14416 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
CHRM3 P20309 1/20 0.38
DRD4 P21917 1/20 0.38
SLC6A2 P23975 1/20 0.38
HRH2 P25021 1/20 0.38
AVPR2 P30518 1/20 0.38
ADRA1A P35348 1/20 0.38
HRH1 P35367 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24110034 0.96 HTR6 (0.44) HTR6KDM4ESMN1; SMN2HTR2AHTR2C
SCHEMBL24110448 0.84 HTR6 (0.43) HTR6KDM4ESMN1; SMN2HTR2AHTR2C
SCHEMBL24110467 0.83 HTR6 (0.45) HTR6KDM4ESMN1; SMN2HTR2AHTR2C
SCHEMBL24109842 0.82 HTR6 (0.41) HTR6KDM4ESMN1; SMN2HTR2AHTR2C
SCHEMBL24110469 0.82 CRHBP (0.33) HTR6HTR2AHTR2CDRD3CHRM2
SCHEMBL24110451 0.81 CRHBP (0.32) HTR6HTR2AHTR2CDRD3CHRM2
SCHEMBL24109826 0.81 HTR6 (0.46) HTR6KDM4ESMN1; SMN2HTR2AHTR2C
SCHEMBL24110460 0.81 HTR6 (0.55) HTR6KDM4EHTR2AHTR2CDRD3
SCHEMBL24110445 0.81 HTR6 (0.55) HTR6KDM4ESMN1; SMN2HTR2AHTR2C
SCHEMBL24110251 0.80 HTR6 (0.44) HTR6KDM4ESMN1; SMN2HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed
WO-2021252692-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. (US) 2021-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF GAP43, SLC18A2, PNMT HTR6 42/4885KDM4E 2739/4885SMN1; SMN2 766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.